H1 2025 Recap: Key Signals from the Tech+Bio Frontier
A high-signal summary of some of the most important moves and trends shaping biotech and tech-enabled life sciences in the first half of 2025.
In this issue: Financial Climate & Deal-Making Power Shift — Gene Therapies are a Mixed Bag — AI Drug Discovery is Recalibrating — Big Data & Data Infrastructures Define Leaders — a Year of Next Generation Sequencing — Away from Animal Models — Brain-Computer Interfaces are Having Momentum
To read the rest of this article, upgrade to a BiopharmaTrend Pro subscription.
Gain full access to all of our deep dives and content archives.
Already a member? Sign in here.
